Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 50 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 9611258

    Dual MEK/PI3K inhibitors and therapeutic methods using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted
  2. US 9603829

    HSP90 inhibitors with modified toxicity

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted
  3. US 9598404

    Deoxycytidine kinase inhibitors

    The Regents of the University of California · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  4. US 9598370

    Prolyl hydroxylase inhibitors and methods of use

    Akebia Therapeutics, Inc. · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  5. US 9596855

    Small molecule inhibitors of biofilm formation and the novel use of previously identified compounds for inhibition of biofilm formation and applications for drug therapy and medical device coating

    The Regents of the University of California · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  6. US 9598424

    Heteroarylamide inhibitors of TBK1

    Takeda Pharmaceutical Company Limited · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  7. US 9592232

    DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  8. US 9593110

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  9. US 9586975

    Macrocyclic salt-inducible kinase inhibitors

    Oncodesign SA · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  10. US 9586890

    Screening methods for the binding affinity of chemical entities to biological molecules and NEDD4-1 inhibitors identified by the screening methods

    Northwestern University · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  11. US 9585882

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  12. US 9580438

    Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and CNS disorders

    4SC DISCOVERY GMBH · Granted Feb 28, 2017 · Expires Feb 23, 2037

    granted
  13. US 9580427

    Kinase inhibitors

    The Regents of the University of California · Granted Feb 28, 2017 · Expires Feb 23, 2037

    granted
  14. US 9580430

    9H-pyrimido[4,5-B]indoles and related analogs as BET bromodomain inhibitors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 28, 2017 · Expires Feb 23, 2037

    granted
  15. US 9573908

    Broad spectrum pro-quorum-sensing molecules as inhibitors of virulence in vibrios

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Feb 21, 2017 · Expires Feb 16, 2037

    granted
  16. US 9567348

    Substituted pyrazolo[1,5-a]pyrimidines as Syk inhibitors

    GILEAD CONNECTICUT, INC. · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted
  17. US 9566278

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted
  18. US 9562056

    Imidazopyridines Syk inhibitors

    GILEAD CONNECTICUT, INC. · Granted Feb 7, 2017 · Expires Feb 2, 2037

    granted
  19. US 9555041

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted
  20. US 9550756

    Pyridazinone compounds as phosphodiesterase inhibitors and methods of treating disorders

    Takeda Pharmaceutical Company Limited · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted
  21. US 9540415

    Inhibitors of the farnesoid X receptor and uses in medicine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted
  22. US 9540337

    Gamma-glutamyl transpeptidase inhibitors and methods of use

    The Board of Regents of the University of Oklahoma · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted
  23. US 9540395

    Histone deacetylase inhibitors

    BIOMARIN PHARMACEUTICAL INC. · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted
  24. US 9533990

    Inhibitors of secretion of hepatitis B virus antigens

    ARBUTUS BIOPHARMA CORPORATION · Granted Jan 3, 2017 · Expires Dec 29, 2036

    granted